Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Jun-12 6:52 PM View:  | Tang Kevin C Director 10% Owner | Ardea Biosciences, Inc. (RDEA) | 19-Jun-12 | Disposition | 15,089 | $32.00 | $482,848.00 | (< 1%) 3.82M to 3.8M | < 1% |
| 20-Jun-12 8:38 PM View: | Manhard Kimberly SVP, Regulatory & Dev Ops | Ardea Biosciences, Inc. (RDEA) | 19-Jun-12 | Market Option Sale | 12,829 | $31.96 | $410,015.00 | (56%) 23.03K to 10.2K | 0% |
| 20-Jun-12 6:48 PM View: | Fuchs Henry J Director | Ardea Biosciences, Inc. (RDEA) | 19-Jun-12 | Disposition | 10,416 | $32.00 | $333,312.00 | (100%) 10.42K to 0 | < 1% |
| 20-Jun-12 6:45 PM View: | Beck John W SVP, Finance & Operations, CFO | Ardea Biosciences, Inc. (RDEA) | 19-Jun-12 | Disposition | 4,409 | $32.00 | $141,088.00 | (100%) 4.41K to 0 | < 1% |
| 20-Jun-12 8:38 PM View: | Manhard Kimberly SVP, Regulatory & Dev Ops | Ardea Biosciences, Inc. (RDEA) | 19-Jun-12 | Option Exercise | 12,829 | $12.20 | $156,524.00 | 126% 10.2K to 23.03K | |
| 20-Jun-12 6:52 PM View: | Tang Kevin C Director 10% Owner | Ardea Biosciences, Inc. (RDEA) | 19-Jun-12 | Disposition | 3,800,630 | $32.00 | $121,620,000.00 | (100%) 3.8M to 0 | < 1% |
| 21-Jun-12 4:13 PM View: | Baker Felix Director 10% Owner | Ardea Biosciences, Inc. (RDEA) | 19-Jun-12 | Disposition | 6,914,290 | $32.00 | $221,256,992.00 | (100%) 6.91M to 0 | |
| 20-Jun-12 6:49 PM View: | Hagerty David T Senior VP & CMO | Ardea Biosciences, Inc. (RDEA) | 19-Jun-12 | Disposition | 140 | $32.00 | $4,480.00 | (100%) 0.14K to 0 | < 1% |
| 20-Jun-12 6:46 PM View: | Davis Stephen EVP & COO | Ardea Biosciences, Inc. (RDEA) | 19-Jun-12 | Disposition | 16,099 | $32.00 | $515,168.00 | (100%) 16.1K to 0 | < 1% |
| 20-Jun-12 8:40 PM View: | Manhard Kimberly SVP, Regulatory & Dev Ops | Ardea Biosciences, Inc. (RDEA) | 19-Jun-12 | Disposition | 10,200 | $32.00 | $326,400.00 | (100%) 10.2K to 0 | < 1% |
| 20-Jun-12 6:51 PM View: | Quart Barry D President and CEO Director | Ardea Biosciences, Inc. (RDEA) | 19-Jun-12 | Disposition | 43,348 | $32.00 | $1,387,140.00 | (100%) 43.35K to 0 | < 1% |
| 12-Jun-12 5:56 PM View: | Beck John W SVP, Finance & Operations, CFO | Ardea Biosciences, Inc. (RDEA) | 11-Jun-12 | Option Exercise | 28,048 | $14.26 | $399,964.00 | 636% 4.41K to 32.46K | |
| 12-Jun-12 5:56 PM View: | Beck John W SVP, Finance & Operations, CFO | Ardea Biosciences, Inc. (RDEA) | 11-Jun-12 | Market Option Sale | 28,048 | $31.97 | $896,695.00 | (86%) 32.46K to 4.41K | 0% |
| 08-Jun-12 7:02 PM View: | Davis Stephen EVP & COO | Ardea Biosciences, Inc. (RDEA) | 06-Jun-12 | Payment of Exercise | 191 | $31.96 | $6,104.36 | (1%) 16.01K to 15.82K | 0% |
| 29-May-12 6:50 PM View: | Manhard Kimberly SVP, Regulatory & Dev Ops | Ardea Biosciences, Inc. (RDEA) | 29-May-12 | Option Exercise | 5,000 | $3.90 | $19,500.00 | 50% 9.97K to 14.97K | |
| 29-May-12 6:50 PM View: | Manhard Kimberly SVP, Regulatory & Dev Ops | Ardea Biosciences, Inc. (RDEA) | 29-May-12 | Market Option Sale (Planned) | 5,000 | $31.89 | $159,430.00 | (33%) 14.97K to 9.97K | < 1% |
| 07-May-12 7:25 PM View: | Davis Stephen EVP & COO | Ardea Biosciences, Inc. (RDEA) | 06-May-12 | Payment of Exercise | 191 | $31.70 | $6,054.70 | (1%) 15.6K to 15.41K | < 1% |
| 30-Apr-12 7:34 PM View: | Manhard Kimberly SVP, Regulatory & Dev Ops | Ardea Biosciences, Inc. (RDEA) | 30-Apr-12 | Market Option Sale (Planned) | 5,000 | $31.82 | $159,078.00 | (34%) 14.73K to 9.73K | (< 1%) |
| 30-Apr-12 7:34 PM View: | Manhard Kimberly SVP, Regulatory & Dev Ops | Ardea Biosciences, Inc. (RDEA) | 30-Apr-12 | Option Exercise | 5,000 | $3.90 | $19,500.00 | 51% 9.73K to 14.73K | |
| 26-Apr-12 7:17 PM View: | Fuchs Henry J Director | Ardea Biosciences, Inc. (RDEA) | 25-Apr-12 | Market Option Sale (Planned) | 10,000 | $31.64 | $316,432.00 | (49%) 20.42K to 10.42K | (< 1%) |
| 26-Apr-12 7:17 PM View: | Fuchs Henry J Director | Ardea Biosciences, Inc. (RDEA) | 25-Apr-12 | Option Exercise | 10,000 | $2.76 | $27,600.00 | 96% 10.42K to 20.42K | |
| 06-Apr-12 7:35 PM View: | Davis Stephen EVP & COO | Ardea Biosciences, Inc. (RDEA) | 06-Apr-12 | Payment of Exercise | 191 | $21.92 | $4,186.72 | (1%) 15.79K to 15.6K | 0% |
| 29-Mar-12 7:32 PM View: | Manhard Kimberly SVP, Regulatory & Dev Ops | Ardea Biosciences, Inc. (RDEA) | 28-Mar-12 | Market Option Sale (Planned) | 5,000 | $22.65 | $113,272.00 | (34%) 14.73K to 9.73K | < 1% |
| 29-Mar-12 7:32 PM View: | Manhard Kimberly SVP, Regulatory & Dev Ops | Ardea Biosciences, Inc. (RDEA) | 28-Mar-12 | Option Exercise | 5,000 | $3.90 | $19,500.00 | 51% 9.73K to 14.73K | |
| 07-Mar-12 7:59 PM View: | Davis Stephen EVP & COO | Ardea Biosciences, Inc. (RDEA) | 06-Mar-12 | Payment of Exercise | 213 | $20.33 | $4,330.29 | (1%) 16.0K to 15.79K | 0% |
| 29-Feb-12 7:40 PM View: | Manhard Kimberly SVP, Regulatory & Dev Ops | Ardea Biosciences, Inc. (RDEA) | 28-Feb-12 | Option Exercise | 5,000 | $3.90 | $19,500.00 | 51% 9.73K to 14.73K | |
| 29-Feb-12 7:40 PM View: | Manhard Kimberly SVP, Regulatory & Dev Ops | Ardea Biosciences, Inc. (RDEA) | 28-Feb-12 | Market Option Sale (Planned) | 5,000 | $20.99 | $104,970.00 | (34%) 14.73K to 9.73K | (2%) |
| 08-Feb-12 6:27 PM View: | Davis Stephen EVP & COO | Ardea Biosciences, Inc. (RDEA) | 06-Feb-12 | Payment of Exercise | 218 | $20.20 | $4,403.60 | (1%) 16.22K to 16.0K | 2% |
| 03-Feb-12 5:52 PM View: | Baker Biotech Capital III (... Director 10% Owner | Ardea Biosciences, Inc. (RDEA) | 01-Feb-12 | Market Purchase | 876,828 | $17.00 | $14,906,100.00 | 22% 4.05M to 4.92M | 11% |
| 03-Feb-12 5:51 PM View: | 14159 Capital (gp, LLC Director 10% Owner | Ardea Biosciences, Inc. (RDEA) | 01-Feb-12 | Market Purchase | 23,172 | $17.00 | $393,924.00 | 25% 93.28K to 116.45K | 11% |
| 03-Feb-12 6:05 PM View: | Tang Kevin C Director 10% Owner | Ardea Biosciences, Inc. (RDEA) | 01-Feb-12 | Market Purchase | 426,470 | $17.00 | $7,249,990.00 | 13% 3.39M to 3.82M | 11% |
| 31-Jan-12 9:25 PM View: | Manhard Kimberly SVP, Regulatory & Dev Ops | Ardea Biosciences, Inc. (RDEA) | 30-Jan-12 | Market Option Sale (Planned) | 5,000 | $18.01 | $90,030.00 | (34%) 14.73K to 9.73K | (< 1%) |
| 31-Jan-12 9:25 PM View: | Manhard Kimberly SVP, Regulatory & Dev Ops | Ardea Biosciences, Inc. (RDEA) | 30-Jan-12 | Option Exercise | 5,000 | $3.90 | $19,500.00 | 51% 9.73K to 14.73K | |
| 06-Jan-12 7:48 PM View: | Davis Stephen EVP & COO | Ardea Biosciences, Inc. (RDEA) | 06-Jan-12 | Payment of Exercise | 218 | $15.55 | $3,389.90 | (1%) 17.14K to 16.92K | (4%) |
| 06-Jan-12 7:48 PM View: | Davis Stephen EVP & COO | Ardea Biosciences, Inc. (RDEA) | 06-Jan-12 | Market Sale (Planned) | 700 | $15.91 | $11,138.00 | (4%) 16.92K to 16.22K | (1%) |
| 29-Dec-11 9:46 PM View: | Manhard Kimberly SVP, Regulatory & Dev Ops | Ardea Biosciences, Inc. (RDEA) | 28-Dec-11 | Market Option Sale (Planned) | 5,000 | $16.97 | $84,861.50 | (34%) 14.73K to 9.73K | (< 1%) |
| 29-Dec-11 9:46 PM View: | Manhard Kimberly SVP, Regulatory & Dev Ops | Ardea Biosciences, Inc. (RDEA) | 28-Dec-11 | Option Exercise | 5,000 | $3.90 | $19,500.00 | 51% 9.73K to 14.73K | |
| 29-Dec-11 9:49 PM View: | Quart Barry D President and CEO Director | Ardea Biosciences, Inc. (RDEA) | 22-Dec-11 | Gift | 10,000 | -- | -- | (19%) 52.89K to 42.89K | |
| 08-Dec-11 7:40 PM View: | Davis Stephen EVP & COO | Ardea Biosciences, Inc. (RDEA) | 06-Dec-11 | Payment of Exercise | 191 | $19.93 | $3,806.63 | (1%) 17.33K to 17.14K | 2% |
| 29-Nov-11 9:13 PM View: | Manhard Kimberly SVP, Regulatory & Dev Ops | Ardea Biosciences, Inc. (RDEA) | 28-Nov-11 | Option Exercise | 5,000 | $3.90 | $19,500.00 | 51% 9.73K to 14.73K | |
| 29-Nov-11 9:13 PM View: | Manhard Kimberly SVP, Regulatory & Dev Ops | Ardea Biosciences, Inc. (RDEA) | 28-Nov-11 | Market Option Sale (Planned) | 5,000 | $17.67 | $88,357.00 | (34%) 14.73K to 9.73K | 1% |
| 20-Dec-11 9:02 PM View: | Quart Barry D President and CEO Director | Ardea Biosciences, Inc. (RDEA) | 16-Nov-11 | Gift | 10,000 | -- | -- | (16%) 62.89K to 52.89K | |
| 17-Nov-11 7:28 PM View: | Davis Stephen EVP & COO | Ardea Biosciences, Inc. (RDEA) | 15-Nov-11 | Market Sale (Planned) | 432 | $18.86 | $8,145.92 | (2%) 17.76K to 17.33K | < 1% |
| 08-Nov-11 8:53 PM View: | Davis Stephen EVP & COO | Ardea Biosciences, Inc. (RDEA) | 06-Nov-11 | Payment of Exercise | 191 | $18.81 | $3,592.71 | (1%) 17.38K to 17.19K | (< 1%) |
| 28-Oct-11 9:43 PM View: | Manhard Kimberly SVP, Regulatory & Dev Ops | Ardea Biosciences, Inc. (RDEA) | 28-Oct-11 | Market Option Sale (Planned) | 5,000 | $21.27 | $106,374.00 | (35%) 14.39K to 9.39K | (1%) |
| 28-Oct-11 9:43 PM View: | Manhard Kimberly SVP, Regulatory & Dev Ops | Ardea Biosciences, Inc. (RDEA) | 28-Oct-11 | Option Exercise | 5,000 | $3.90 | $19,500.00 | 53% 9.39K to 14.39K | |
| 07-Oct-11 9:12 PM View: | Davis Stephen EVP & COO | Ardea Biosciences, Inc. (RDEA) | 06-Oct-11 | Payment of Exercise | 191 | $15.73 | $3,004.43 | (1%) 18.27K to 18.08K | (< 1%) |
| 07-Oct-11 9:12 PM View: | Davis Stephen EVP & COO | Ardea Biosciences, Inc. (RDEA) | 06-Oct-11 | Market Sale (Planned) | 700 | $15.43 | $10,803.10 | (4%) 18.08K to 17.38K | (2%) |
| 30-Sep-11 8:28 PM View: | Manhard Kimberly SVP, Regulatory & Dev Ops | Ardea Biosciences, Inc. (RDEA) | 28-Sep-11 | Market Option Sale (Planned) | 5,000 | $16.28 | $81,423.00 | (35%) 14.39K to 9.39K | 2% |
| 30-Sep-11 8:28 PM View: | Manhard Kimberly SVP, Regulatory & Dev Ops | Ardea Biosciences, Inc. (RDEA) | 28-Sep-11 | Option Exercise | 5,000 | $3.90 | $19,500.00 | 53% 9.39K to 14.39K |
